Sopharma AD plans to build the new lyophilic factory in Sofia in the first half of 2018. With the construction of the plant Sopharma AD will double the capacity of its current production facilities, which will ensure the production of sufficient quantities of the life-saving hospital product Methylprednisolone and will create additional workplaces. The built-up area will be about 3000 square meters, the building is planned to be two-storey and include both production and service spaces which are of particular importance for this highest-grade production because they provide the necessary purified water, humidity, purity, temperature and air pressure in the internal production environment, purified steam, etc. The whole project is expected to cost around 30 million leva.